Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 12 847 / https://doi.org/10.3332/ecancer.2018.847

Clinical Study

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study

Background: Financial toxicity (FT) has a negative impact on the quality of life and survival of patients with cancer. The comprehensive score for FT (COST) questionnaire is a tool to measure FT which has already been validated in patients with cancer in the United States. However, the feasibility and validity of assessing FT using the COST questionnaire have not been established in non-US healthcare settings, including that in Japan.

Methods: This is a prospective pilot survey to ascertain the feasibility of using the COST questionnaire to evaluate FT in Japanese patients with advanced solid cancer who had been receiving chemotherapy for at least 2 months. The COST questionnaire was translated into Japanese using Functional Assessment of Chronic Illness Therapy methodology.

Results: Of the 12 patients approached, 11 (92%) responded to the questionnaire. The median COST score was 22 (range, 6–29; mean ± SD, 20.18 ± 8.17). Five (45%) and two (18%) patients suffered grade 1 (COST score 14–25) and grade 2 (COST score 1–13) FT, respectively. The COST measure demonstrated good internal consistency with a Cronbach α of 0.87.

Conclusions: The COST measure demonstrated good feasibility in measuring FT in the Japanese healthcare setting. Despite the existing universal health insurance system and ceiling amount for high-cost medical expenses, some Japanese patients experienced meaningful FT during chemotherapy. A prospective study is already underway to confirm the preliminary results (UMIN: 000025043).

Keywords: financial toxicity, cost, cancer, Japan, health insurance

Categories:

Economics

Loading Article Metrics ... Please wait

Related articles

Case Report: Peliosis hepatis associated with follicular lymphoma with a rise in vascular endothelial growth factor and anaemia of inflammation

Abstract | Full Article | PDF | Spanish Published: 20 Nov 2018 / https://doi.org/10.3332/ecancer.2018.882

Short Communication: Learning from the past to design better trials in second-line treatment for mesothelioma patients

Abstract | Full Article | PDF Published: 08 Nov 2018 / https://doi.org/10.3332/ecancer.2018.881

Research: Information sources and online information seeking behaviours of cancer patients in Singapore

Abstract | Full Article | PDF Published: 31 Oct 2018 / https://doi.org/10.3332/ecancer.2018.880

Clinical Study: High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease

Abstract | Full Article | PDF Published: 25 Oct 2018 / https://doi.org/10.3332/ecancer.2018.879

Research: Identifying barriers and finding solutions to implement best practices for cancer surgery at Maputo Central Hospital, Mozambique

Abstract | Full Article | PDF Published: 23 Oct 2018 / https://doi.org/10.3332/ecancer.2018.878



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation